Stay updated on ADXS-503 & Pembro in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the ADXS-503 & Pembro in Lung Cancer Clinical Trial page.

Latest updates to the ADXS-503 & Pembro in Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study record for the ADXS-503 lung cancer trial is displayed, including its design, eligibility criteria, locations, interventions, outcome measures, and posted results.SummaryDifference65%

- Check15 days agoChange DetectedThe site revision shown in the footer changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide notice announces a transition in NIH terminology, stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the error page.SummaryDifference0.2%

- Check50 days agoChange DetectedThe study page now shows a 403 Forbidden error with a minimal header and a Home link, indicating the page is currently inaccessible.SummaryDifference0.5%

Stay in the know with updates to ADXS-503 & Pembro in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADXS-503 & Pembro in Lung Cancer Clinical Trial page.